Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Leichman

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Research|August 1, 1983
Phase I evaluation and pharmacokinetics of aziridinylbenzoquinone using a weekly intravenous scheduleR B Schilcher, J D Young, L P Leichman, et al.
Cancer Treatment Reports|October 1, 1980
Mitomycin C and bleomycin in the treatment of far-advanced cervical cancer: a Southwest Oncology Group pilot studyL P Leichman, L H Baker, C R Stanhope, et al.
Journal of the National Cancer Institute|October 16, 1996
Failure of pretreatment with intravenous folic acid to alter the cumulative hematologic toxicity of lometrexolF M Muggia, T W Synold, E M Newman, et al.
Cancer|February 1, 1995
A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancerL B Saltz, C G Leichman, C W Young, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and siteH J Lenz, K D Danenberg, C G Leichman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survivalH J Lenz, K Hayashi, D Salonga, et al.
Oncogene|October 23, 1997
High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomachK Hayashi, R Metzger, D Salonga, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Research|August 1, 1983
Phase I evaluation and pharmacokinetics of aziridinylbenzoquinone using a weekly intravenous scheduleR B Schilcher, J D Young, L P Leichman, et al.
Cancer Treatment Reports|October 1, 1980
Mitomycin C and bleomycin in the treatment of far-advanced cervical cancer: a Southwest Oncology Group pilot studyL P Leichman, L H Baker, C R Stanhope, et al.
Journal of the National Cancer Institute|October 16, 1996
Failure of pretreatment with intravenous folic acid to alter the cumulative hematologic toxicity of lometrexolF M Muggia, T W Synold, E M Newman, et al.
Cancer|February 1, 1995
A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancerL B Saltz, C G Leichman, C W Young, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and siteH J Lenz, K D Danenberg, C G Leichman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survivalH J Lenz, K Hayashi, D Salonga, et al.
Oncogene|October 23, 1997
High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomachK Hayashi, R Metzger, D Salonga, et al.
Pageof 2